BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9349461)

  • 1. Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.
    Schofield DJ; Stephenson JR; Dimmock NJ
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2431-9. PubMed ID: 9349461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition.
    Edwards MJ; Dimmock NJ
    Virology; 2000 Dec; 278(2):423-35. PubMed ID: 11118365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
    Edwards MJ; Dimmock NJ
    J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
    Williams JA; Gui L; Hom N; Mileant A; Lee KK
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of affinities of a panel of IgGs and Fabs for whole enveloped (influenza A) virions using surface plasmon resonance.
    Schofield DJ; Dimmock NJ
    J Virol Methods; 1996 Oct; 62(1):33-42. PubMed ID: 8910646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.
    Edwards MJ; Dimmock NJ
    J Gen Virol; 2001 Jun; 82(Pt 6):1387-1395. PubMed ID: 11369883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus.
    Schofield DJ; Stephenson JR; Dimmock NJ
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2441-6. PubMed ID: 9349462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?
    Yoden S; Kida H; Yanagawa R
    Arch Virol; 1985; 85(3-4):209-16. PubMed ID: 2411245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All rabbits immunized with type A influenza virions have a serum haemagglutination-inhibition antibody response biased to a single epitope in antigenic site B.
    Lambkin R; Dimmock NJ
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():889-97. PubMed ID: 9049335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.
    Feng JQ; Mozdzanowska K; Gerhard W
    J Virol; 2002 Feb; 76(3):1369-78. PubMed ID: 11773411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.
    Pitaksajjakul P; Lekcharoensuk P; Upragarin N; Barbas CF; Ibrahim MS; Ikuta K; Ramasoota P
    Biochem Biophys Res Commun; 2010 May; 395(4):496-501. PubMed ID: 20382115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative relationships between an influenza virus and neutralizing antibody.
    Taylor HP; Armstrong SJ; Dimmock NJ
    Virology; 1987 Aug; 159(2):288-98. PubMed ID: 3617501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
    Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
    Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from lethal coronavirus infection by immunoglobulin fragments.
    Lamarre A; Talbot PJ
    J Immunol; 1995 Apr; 154(8):3975-84. PubMed ID: 7706736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.
    Mozdzanowska K; Feng J; Gerhard W
    J Virol; 2003 Aug; 77(15):8322-8. PubMed ID: 12857901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
    Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
    J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency.
    Shen C; Zhang M; Chen Y; Zhang L; Wang G; Chen J; Chen S; Li Z; Wei F; Chen J; Yang K; Guo S; Wang Y; Zheng Q; Yu H; Luo W; Zhang J; Chen H; Chen Y; Xia N
    Theranostics; 2019; 9(1):210-231. PubMed ID: 30662563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of neutralization of influenza virus infectivity by antibodies.
    Knossow M; Gaudier M; Douglas A; Barrère B; Bizebard T; Barbey C; Gigant B; Skehel JJ
    Virology; 2002 Oct; 302(2):294-8. PubMed ID: 12441073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies.
    Gitelman AK; Kaverin NV; Kharitonenkov IG; Rudneva IA; Sklyanskaya EL; Zhdanov VM
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2247-51. PubMed ID: 3760825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.